Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial.

Leonie Exterkate,Olivier Wegelin,Jelle O Barentsz,Marloes G van der Leest,J Alain Kummer,Willem Vreuls,Peter C de Bruin,J Alfred Witjes,Harm H E van Melick,Diederik M Somford

BJU international（2023）

引用 0|浏览17

暂无评分

摘要

After negative prior biopsy and non-suspicious mpMRI the risk of csPCa is low. However, compared to the general population, the risk of csPCa is increased despite the high negative predictive value of mpMRI. More research focusing on biochemical and image-guided risk-adapted diagnostic surveillance strategies is warranted.

查看译文

关键词

#PCSM,#ProstateCancer,#uroonc,diagnostic surveillance,follow-up,multiparametric magnetic resonance imaging,prostate biopsy,prostate cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要